UBS Asset Management Americas Inc. purchased a new position in shares of National HealthCare Co. (NYSEAMERICAN:NHC) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 2,701 shares of the company’s stock, valued at approximately $219,000.
Other large investors also recently made changes to their positions in the company. Parallel Advisors LLC raised its stake in National HealthCare by 1,013.4% during the 2nd quarter. Parallel Advisors LLC now owns 1,748 shares of the company’s stock worth $142,000 after acquiring an additional 1,591 shares in the last quarter. First Trust Advisors LP increased its stake in National HealthCare by 28.0% in the second quarter. First Trust Advisors LP now owns 20,805 shares of the company’s stock valued at $1,688,000 after purchasing an additional 4,547 shares during the period. Aperio Group LLC increased its stake in National HealthCare by 4.9% in the second quarter. Aperio Group LLC now owns 27,554 shares of the company’s stock valued at $2,236,000 after purchasing an additional 1,275 shares during the period. WINTON GROUP Ltd acquired a new position in National HealthCare in the second quarter valued at $1,027,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in National HealthCare by 56.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 581 shares of the company’s stock valued at $47,000 after purchasing an additional 209 shares during the period.
In other news, Director James Paul Abernathy sold 1,714 shares of the business’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $84.78, for a total transaction of $145,312.92. Following the transaction, the director now directly owns 22,019 shares in the company, valued at $1,866,770.82. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Ernest G. Burgess III sold 3,000 shares of the business’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $82.25, for a total transaction of $246,750.00. Following the transaction, the director now owns 97,114 shares in the company, valued at $7,987,626.50. The disclosure for this sale can be found here.
National HealthCare (NYSEAMERICAN:NHC) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.84 EPS for the quarter. The business had revenue of $247.15 million during the quarter.
The firm also recently disclosed a dividend, which will be paid on Monday, December 2nd. Shareholders of record on Monday, September 30th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, September 27th.
National HealthCare Profile
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, and home health care programs. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities.
Further Reading: Understanding Market Liquidity
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.